| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2004 | CA2494971A1 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | CA2494841A1 Bacterial effector proteins which inhibit programmed cell death |
| 02/26/2004 | CA2494293A1 Treatment of liver deseases |
| 02/26/2004 | CA2493928A1 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 02/26/2004 | CA2493925A1 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 02/26/2004 | CA2493923A1 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer |
| 02/26/2004 | CA2493921A1 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
| 02/26/2004 | CA2493822A1 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | CA2492932A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | CA2492930A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1391518A1 Process for producing peptide |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391512A1 Polypeptide serving as angiogenic marker and dna thereof |
| 02/25/2004 | EP1391509A1 Transformed silkworm producing human collagen |
| 02/25/2004 | EP1391508A1 Transgenic nematode expressing mammalian GPCRS used for screening assay |
| 02/25/2004 | EP1391502A1 Host microorganisms |
| 02/25/2004 | EP1391463A1 GPI anchored glycoprotein ACA as a novel tumor marker |
| 02/25/2004 | EP1391462A1 Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| 02/25/2004 | EP1390755A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 02/25/2004 | EP1390744A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 02/25/2004 | EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390535A2 Combinatorial libraries of monomer domains |
| 02/25/2004 | EP1390514A2 Regulatory protein involved in pectin modification |
| 02/25/2004 | EP1390507A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390504A2 Nucleotide sequences which code for the metd gene |
| 02/25/2004 | EP1390503A2 Novel nucleic acid molecules |
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390501A1 Determination of a genetic predisposition for behavioural disorders |
| 02/25/2004 | EP1390500A1 Transgenic non-human animals for pharmacological and toxicological studies |
| 02/25/2004 | EP1390499A2 Cell visual characteristic-modifying sequences |
| 02/25/2004 | EP1390498A2 Gab2(p97) gene and methods of use thereof |
| 02/25/2004 | EP1390497A2 Human cdnas and proteins and uses thereof |
| 02/25/2004 | EP1390496A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 02/25/2004 | EP1390491A1 Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors |
| 02/25/2004 | EP1390487A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis |
| 02/25/2004 | EP1390486A2 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 02/25/2004 | EP1390485A1 Removal of plasmin(ogen) from protein solutions |
| 02/25/2004 | EP1390483A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 02/25/2004 | EP1390478A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390408A1 A molecular marker |
| 02/25/2004 | EP1390407A2 The lectin-like domain of thrombomodulin and its therapeutic use |
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390404A2 Interleukin-1 related gene and protein |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390402A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/25/2004 | EP1390401A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390399A2 Long lasting fusion peptide inhibitors for hiv infection |
| 02/25/2004 | EP1390398A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 02/25/2004 | EP1390397A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine |
| 02/25/2004 | EP1390396A2 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390394A2 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390390A2 Human secreted proteins |
| 02/25/2004 | EP1390387A2 Cancer-testis antigens |
| 02/25/2004 | EP1390384A2 Chromosome-based platforms |
| 02/25/2004 | EP1390381A2 Lipid metabolism regulators in plants |
| 02/25/2004 | EP1390379A1 Kindling fluorescent proteins and methods for their use |
| 02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
| 02/25/2004 | EP1390074A1 Novel compositions and uses therefor |
| 02/25/2004 | EP1390061A2 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1389997A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 02/25/2004 | EP1389941A2 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity |
| 02/25/2004 | EP1389903A2 Feed additive compositions and methods |
| 02/25/2004 | EP1276763B1 Anti-freeze proteins, their production and use |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1086135B1 "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)" |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0969726B1 Treatment for dutch elm disease |
| 02/25/2004 | EP0967224B1 Fish protein, its gene, reagents for inducing apoptosis, and anticancer agents |
| 02/25/2004 | EP0948351B1 Synthetic hpv16 virus-like particles |
| 02/25/2004 | EP0869976B1 Design of hormone-like antibodies with agonistic and antagonistic functions |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0759987B1 Antibody against human restrictin |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0749478B1 Yeast strains and modified albumins |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN2604441Y Apparatus for producing high-absorbance rhodophyll with Helminthocladiaceae |
| 02/25/2004 | CN2604440Y Arrangement for producing high-absorbance rhodophyll with ceylon sea membrance |
| 02/25/2004 | CN1478148A Novel transcriptional factor enhancing resistance of plants to osmotic stress |
| 02/25/2004 | CN1478147A Composition of carrier granules capable of producing RNA virus and based on RNA virus and its method |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478097A Method and cell for detecting modulations of RGS proteins |
| 02/25/2004 | CN1477972A Method for botaining antigenic aggregates and use thereof in formulations |
| 02/25/2004 | CN1477969A Chemokine mutants in treatment of multiple sclerosis |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477126A Long-acting growth hormone and medicine composition |
| 02/25/2004 | CN1477125A A polypeptide-human amelification protein 23 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477124A A polypeptide-zinc finger protein 42 and polynucleotide for coding said polypeptide |
| 02/25/2004 | CN1477123A A polypeptide-transcription factor 43 and polynucleotide coding said polypeptide |
| 02/25/2004 | CN1477122A A polypeptide-human blood vessel epithelial calcium adhesion protein 54 and polynuceotide for coding said polypeptide |